The loss of an exceptional young man to non-Hodgkin’s lymphoma at age 30 served as the inspiration for the creation of an outstanding fundraising endeavor. Under the direction of Stephen J. Forman, M.D., chair, Division of Hematology & Hemaptopoietic Cell Transplantation at City of Hope, friends and family members established the Tim Nesvig Fellowship for Lymphoma Research Fund to further understand the underlying causes of lymphoma and develop better treatment options for patients.
The 2008 recipient of the Tim Nesvig Lymphoma Fellowship, an assistant professor in City of Hope's Division of Hematology & Hematopoietic Cell Transplantation, intends to use the fellowship to further the development of a novel immunotherapy drug. Nakamura began developing an immunocytokine to treat lymphoma five years ago. It is an engineered fusion protein that combines two proteins to attack lymphoma cells. Nakamura will continue his research into immune system changes in patients who receive the immunocytokine as well as ways to boost those immune responses. He hopes to design the fusion protein so that it enables the patient’s immune system to create antibodies that identify and fight off lymphoma cells, which also may help the patient avoid relapse after treatment.
More information on Dr. Nakamura >>
2007, Mark Kirschbaum, M.D.
2006, Leslie Popplewell, M.D.
2005, Aung Naing, M.D.